Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan. (Q45359396)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

13

Hiromitsu Kumada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1

Fumitaka Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

11

Kenji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

9

Masahiro Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

3

Yoshiyuki Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

4

Norio Akuta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

2

Yasuji Arase

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

5

Hitomi Sezaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

7

Yusuke Kawamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

12

Mariko Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

10

Satoshi Saito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Yuya Seko

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

24 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

814-822

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22361865%20AND%20SRC:MED&resulttype=core&format=json

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

24 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Management of hepatitis B: 2000--summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Long-term efficacy of interferon alpha therapy on hepatitis B viral replication in patients with chronic hepatitis B: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Randomized, controlled trial of natural interferon-alpha therapy for e-antigen-positive chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Classification of hepatitis B virus genotypes by the PCR-Invader method with genotype-specific probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Hepatitis B genotypes and the response to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0548-5

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study

21 January 2018

1 reference

12 December 2020

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

12 December 2020

A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg

1 reference

12 December 2020

Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B

1 reference

12 December 2020

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

12 December 2020

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

12 December 2020

Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine

1 reference

12 December 2020

The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B

1 reference

12 December 2020

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

12 December 2020

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1 reference

12 December 2020

A randomized, double-blind, controlled trial of natural interferon-beta therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels

1 reference

12 December 2020